Also, inhibition of BMI1, which is a key role in LSC self-renewal and advancement of CML to the acute level through blocking a defensive CCNG2-dependent autophagy pathway, combined with IM significantly reduces the clonogenic properties of CD34+ CML cells [178]. Here, BMI1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.